2m 2m 2m 2m 2m 2m 2m
Exozymes (EXOZ)
NASDAQ
$3.96+$0.06 (+1.41%)
Price as of Oct 23, 2026 4:10 PM EDT- $36.3MMarket Cap
- -67.50%1-Year Change
- BiotechnologyIndustry
Exozymes (EXOZ)
$3.96+$0.06 (+1.41%)
EXOZ | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.90 | ||
Change | -$0.02 (-0.51%) | ||
Open | $3.80 | ||
High | $4.64 | ||
Low | $3.80 | ||
Previous Close | $3.92 | ||
Volume | 26,491 | ||
30-Day Average Volume | 10,581 | ||
1-Week Change | -2.50% | ||
1-Month Change | -37.00% | ||
1-Year Change | -67.50% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 9.3M | ||
Total Assets | $8.0M | ||
Market Cap | $36.3M | ||
Enterprise Value | $30.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.6M | ||
EBIT | $0.00 | ||
EBITDA | $76,949.00 | ||
Net Working Capital | $4.6M | ||
EPS | -$0.33 | ||
Enterprise Value/EBITDA | 398 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 10 | ||
P/E | -12 | ||
PEG | 1 | ||
Price/Free Cash Flow | -22 | ||
Price/Operating Cash Flow | -22 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue